Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.
纤溶酶原激活物抑制剂-1介导非小细胞肺癌对PD-1抗免疫疗法的耐受性。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-24-0890
Sumii Masahiko, Masuda Takeshi, Shimoji Kiyofumi, Yamaguchi Kakuhiro, Sakamoto Shinjiro, Horimasu Yasushi, Mimae Takahiro, Nakashima Taku, Iwamoto Hiroshi, Miyata Yoshihiro, Hamada Hironobu, Okada Morihito, Miyata Toshio, Hattori Noboru